Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SPECIALISTS IN PAIN MANAGEMENT, PLLC DBA SPINE & PAIN ASSOCIATES

NPI: 1447203922 · CHATTANOOGA, TN 37404 · Interventional Pain Medicine Physician · NPI assigned 05/18/2006

$281K
Total Medicaid Paid
56,796
Total Claims
38,263
Beneficiaries
21
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSMITH, LORI (REVENUE CYCLE DIRECTOR)
NPI Enumeration Date05/18/2006

Related Entities

Other providers sharing the same authorized official: SMITH, LORI

ProviderCityStateTotal Paid
WILSON COUNTY HOSPITAL NEODESHA KS $1.63M
WILSON COUNTY HOSPITAL CHERRYVALE KS $451K
WILSON COUNTY HOSPITAL INDEPENDENCE KS $271K
WILSON COUNTY HOSPITAL NEODESHA KS $255K
WILSON COUNTY HOSPITAL NEODESHA KS $2K
MEANINGFUL PSYCHIATRIC SERVICES LLC LINCOLN NE $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,096 $46K
2019 10,711 $27K
2020 6,583 $27K
2021 7,010 $28K
2022 7,143 $32K
2023 7,459 $41K
2024 6,794 $79K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28,615 19,098 $193K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 11,405 7,689 $28K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 12,873 8,522 $28K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 271 204 $9K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 538 413 $5K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 903 738 $4K
99205 Prolong outpt/office vis 192 159 $4K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 329 265 $3K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 179 156 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 117 53 $1K
80305 908 605 $1K
80306 57 56 $498.20
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 26 12 $398.39
90791 Psychiatric diagnostic evaluation 17 14 $356.19
96130 17 14 $290.11
96139 17 14 $229.57
G0444 Annual depression screening, 5 to 15 minutes 169 139 $211.55
96138 17 14 $142.38
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 78 51 $128.42
99484 20 14 $84.75
99406 48 33 $61.88